Annual Report And Financial Statements

Overview

The report describes BioPharma Credit PLC as an investment trust with no employees and outsourced operations, with the Board engaging the Investment Manager on ESG matters. It explains that insufficient reliable, timely and verifiable data prevented assessment of investments using the EU Taxonomy Technical Screening Criteria. The report also presents Pharmakon’s employee profile of 7 people, including 29% female representation, and states that the Board monitors ESG policy compliance across portfolio companies.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 21 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services